SCRIPT have created the following guidance on how information technology systems can support safe practice in anti-D Ig management in pregnancy, including:
- Potentially sensitising events (10-20 weeks)
- Non-Invasive Prenatal Testing for Fetal Rh-D genotype (cffDNA)
- Potentially sensitising events (from 20 weeks)
- Routine antenatal anti-D Ig prophylaxis (RAADP)
- Post delivery
IT-supports-anti_D-Ig-management (pdf)
